World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism

No abstract is available for this paper.

• Publication year

  2008

• Venue

  World Journal of Biological Psychiatry

• Publication date

  2008-01-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1080/15622970801896390PMID 18273737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opioid antagonists for alcohol dependence.

  2010cited by this paper
• The prevalence of what?

  2009cited by this paper
• Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study.

  2009cited by this paper
• Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) Part 1: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part I: Acute and continuation treatment of major depressive disorder

  2009cited by this paper
• Acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes

  2008influential reference
• Diagnostic and Statistical Manual of Mental Disorders

  2008cited by this paper
• GABA-A2 receptor subunit gene (GABRA2) polymorphisms and risk for alcohol dependence.

  2008cited by this paper
• Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.

  2007cited by this paper
• Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam.

  2007cited by this paper
• Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats.

  2007cited by this paper
• Treatment of Depression in Patients With Alcohol or Other Drug Dependence

  2007cited by this paper
• Topiramate for treating alcohol dependence: a randomized controlled trial.

  2007cited by this paper
• Topiramate (Topamax) reduces conditioned abstinence behaviours and handling-induced convulsions (HIC) after chronic administration of alcohol in Swiss-Webster mice.

  2007cited by this paper
• Effects of topiramate.

  2007cited by this paper
• Topiramate reduces ethanol consumption by C57BL/6 mice

  2007cited by this paper
• New pharmacological approaches for the treatment of alcoholism

  2006cited by this paper
• An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants.

  2006cited by this paper
• Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

  2006influential reference
• The effects of alcohol and drug dependence on the course of depression.

  2006influential reference
• Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder.

  2006cited by this paper
• Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.

  2006cited by this paper
• Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: additional evidence.

  2006cited by this paper
• Currently active and remitted alcohol dependence in a nationwide adult general population--results from the Finnish Health 2000 study.

  2006influential reference
• A Rational Approach to the Pharmacotherapy of Alcohol Dependence

  2006cited by this paper
• Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

  2006cited by this paper
• Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder

  2006cited by this paper
• Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.

  2006cited by this paper
• Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis

  2006cited by this paper
• Sertraline Treatment of Co-occurring Alcohol Dependence and Major Depression

  2006cited by this paper
• Association between GABRA1 and drinking behaviors in the collaborative study on the genetics of alcoholism sample.

  2006cited by this paper
• Evidence-based treatments for alcohol dependence: new results and new questions.

  2006cited by this paper
• Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.

  2006cited by this paper
• Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors

  2006cited by this paper
• [The effectiveness of psychosocial treatment approaches for alcohol dependence--a review].

  2006cited by this paper
• Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

  2006cited by this paper
• Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.

  2005cited by this paper
• The prevalence and impact of alcohol problems in major depression: a systematic review.

  2005cited by this paper
• Safety and efficacy of GABAergic medications for treating alcoholism.

  2005cited by this paper
• Alcohol use disorders in EU countries and Norway: an overview of the epidemiology.

  2005cited by this paper
• Role of the endocannabinoid system in the development of tolerance to alcohol.

  2005cited by this paper
• Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.

  2005cited by this paper
• GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study

  2005cited by this paper
• Clock reset for alcoholism

  2005cited by this paper
• Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence

  2005cited by this paper
• The Efficacy and Safety of Topiramate in the Treatment of Alcohol Withdrawal

  2005cited by this paper
• EFNS guideline on the diagnosis and management of alcohol‐related seizures: report of an EFNS task force

  2005cited by this paper
• Effektivität psychosozialer Behandlungsmethoden zur medizinischen Rehabilitation alkoholabhängiger Patienten

  2005cited by this paper
• Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.

  2005cited by this paper
• Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.

  2005cited by this paper
• Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population.

  2005cited by this paper
• Thalamic hypofunction in alcohol hallucinosis: FDG PET findings.

  2005cited by this paper
• Association Between Alcoholism and γ‐Amino Butyric Acid α2 Receptor Subtype in a Russian Population

  2005cited by this paper
• The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption

  2005cited by this paper
• Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial

  2005cited by this paper
• Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.

  2005cited by this paper
• Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats

  2005cited by this paper
• An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence.

  2005cited by this paper
• Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions

  2005cited by this paper
• Schizophrenia and comorbid substance use disorder: effects of antipsychotics.

  2005cited by this paper
• Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice.

  2005cited by this paper
• Co-Occurrence of 12-Month Alcohol and Drug Use Disorders and Personality Disorders in the United States

  2004cited by this paper
• Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.

  2004cited by this paper
• Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations.

  2004cited by this paper
• A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence.

  2004cited by this paper
• Management of alcohol withdrawal delirium. An evidence-based practice guideline.

  2004cited by this paper
• EFFICACY AND SAFETY OF

  2004cited by this paper
• Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.

  2004cited by this paper
• Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial.

  2004cited by this paper
• Effectiveness of naltrexone in a community treatment program.

  2004cited by this paper
• The 12-Month Prevalence and Trends in DSM–IV Alcohol Abuse and Dependence

  2004cited by this paper
• Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance—a pilot study

  2004cited by this paper
• The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis.

  2004cited by this paper
• Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

  2004influential reference
• Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2.

  2004cited by this paper
• A Multi-site Dose Ranging Study of Nalmefene in the Treatment of Alcohol Dependence

  2004cited by this paper
• Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study.

  2004cited by this paper
• Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity.

  2004cited by this paper
• Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.

  2004cited by this paper
• Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods.

  2003cited by this paper
• Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study.

  2003cited by this paper
• Targeted Naltrexone for Early Problem Drinkers

  2003cited by this paper
• The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between metabotropic glutamate type 5 receptors and N-methyl-D-aspartate receptors.

  2003cited by this paper
• Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.

  2003cited by this paper
• RETRACTED ARTICLE: Acamprosate and its efficacy in treating alcohol dependent adolescents

  2003cited by this paper
• Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.

  2003cited by this paper
• Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone.

  2003cited by this paper
• Treating alcohol and drug abuse : an evidence based review

  2003influential reference
• Seizures in Alcohol-Dependent Patients

  2003cited by this paper
• Candidate genes for alcohol dependence: animal studies.

  2003cited by this paper
• Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study.

  2003cited by this paper
• Acamprosate blocks the increase in dopamine extracellular levels in nucleus accumbens evoked by chemical stimulation of the ventral hippocampus

  2003cited by this paper
• A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.

  2003cited by this paper
• Efficacy of acamprosate in the treatment of alcohol-dependent outpatients.

  2003cited by this paper
• Alcoholism: allostasis and beyond.

  2003cited by this paper
• Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

  2003cited by this paper
• Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.

  2003cited by this paper
• Treating Alcohol and Drug Abuse

  2003influential reference
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder

  2002cited by this paper
• The use of divalproex in alcohol relapse prevention: a pilot study.

  2002cited by this paper
• Chronic alcohol use and first symptomatic epileptic seizures

  2002cited by this paper

• Alcohol use disorder: who thinks about addiction? The role of mutual-self-help.

  2025cites this paper
• Therapeutic potential of faecal microbiota transplantation for alcohol use disorder, a narrative synthesis.

  2025cites this paper
• Switching from Antipsychotic Polypharmacy to Monotherapy in Hebephrenic Schizophrenia: A Case Study

  2025cites this paper
• Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations

  2024cites this paper
• Comparative efficacy of various pharmacologic treatments for alcohol withdrawal syndrome: a systematic review and network meta-analysis

  2023cites this paper
• Alcohol use disorders, self-help groups as a supplement to pharmacological and psychological therapy? A retrospective study in a population with alcohol related liver disease.

  2022cites this paper
• Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta-analysis.

  2022cites this paper
• Management of Post-Acute Alcohol Withdrawal: A Mixed-Studies Scoping Review.

  2022cites this paper
• The introduction of the self help groups facilitator in a hepato-alcohologic service: an innovative proposal.

  2021cites this paper
• Differential Influence of Pueraria lobata Root Extract and Its Main Isoflavones on Ghrelin Levels in Alcohol-Treated Rats

  2021cites this paper
• The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders

  2020cites this paper
• Alcohol, liver disease and the gut microbiota

  2019cites this paper
• Targeting Microbiota: What Do We Know about It at Present?

  2019cites this paper
• Overcoming Alcohol Addiction in Patients with Alcohol-Related Liver Disease

  2019cites this paper
• Alcohol or Gut Microbiota: Who Is the Guilty?

  2019cites this paper
• Long-term pharmacotherapy aimed at maintaining abstinence or reducing alcohol intake in alcohol-dependent individuals. Guidelines from the Section of Pharmacotherapy of Polish Society for Research on Addictions (PTBU) and the Section of Psychopharmacology of Polish Psychiatric Association (PTP) – 20

  2019influential citation
• Disulfiram in the Management of Alcohol Dependence

  2019cites this paper
• Nutritional Status During Inpatient Alcohol Detoxification

  2018cites this paper
• Use of antipsychotic blood levels in clinician decision making: A cross-over study using clinical vignettes of patients with schizophrenia.

  2018cites this paper
• Filling the gap between lab and clinical impact: An open randomized diagnostic trial comparing urinary ethylglucuronide and ethanol in alcohol dependent outpatients.

  2018cites this paper
• Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder

  2017cites this paper
• Le traitement par thiamine (vitamine B1) dans l’alcoolodépendance

  2017cites this paper
• Dispositional and situational coping among individuals with alcohol use disorder.

  2017cites this paper
• The role of the dopamine system in the ability of (-)-OSU6162 to reduce voluntary alcohol drinking and binge-eating in the rat

  2017cites this paper
• [Thiamine (vitamin B1) treatment in patients with alcohol dependence].

  2017cites this paper
• Psychosocial difficulties from the perspective of persons with neuropsychiatric disorders

  2016cites this paper
• Liver Transplantation for Alcoholic Liver Disease.

  2016cites this paper
• Treatment of alcohol use disorders in patients with alcoholic liver disease.

  2016cites this paper
• Delirium as a complication of the surgical intensive care

  2016cites this paper
• Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential

  2016cites this paper
• La psiquiatría de enlace y el diagnóstico del delirium tremens

  2016cites this paper
• Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis

  2016cites this paper
• Training in Substance-Related and Addictive Disorders, Part 1: Overview of Clinical Practice and General Recommendations.

  2015cites this paper
• The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the treatment of adolescent sexual offenders with paraphilic disorders

  2015cites this paper
• Prevention of homicidal behaviour in men with psychiatric disorders

  2015cites this paper
• Buprenorphine–naloxone buccal soluble film for the treatment of opioid dependence: current update

  2015cites this paper
• *Abridged version of the "Therapeutic Guideline for Alcohol Use Disorder" prepared by the Working Group Therapeutic Guideline for Alcohol Use Disorder.

  2015cites this paper
• [Nalmefene: a novel pharmacotherapeutic option for alcoholism].

  2014cites this paper
• Disulfiram in the management of alcohol dependence: A comprehensive clinical review

  2014cites this paper
• Preditores de Abstinência Alcoólica numa Amostra de Doentes Portugueses - Um Estudo Retrospectivo Predictors of Continuous Alcohol Abstinence in a Portuguese Treatment Sample - A Retrospective Study

  2014cites this paper
• Nalmefene for the treatment of alcohol dependence: a current update.

  2014cites this paper
• Understanding access to drug and alcohol treatment services in Europe: A multi-country service users’ perspective

  2014cites this paper
• [Pharmacological features of naltrexone and its use in the treatment of alcohol dependence].

  2013cites this paper
• Alcohol-induced psychotic disorder: a review

  2013cites this paper
• The use of naltrexone in the treatment of alcohol dependence : pharmacological aspects

  2013cites this paper
• Reduction of harmful consumption versus total abstinence in addiction treatment

  2013cites this paper
• [Abstinence in alcohol-dependence: critical and updated approach of the 2001 national guidelines].

  2013cites this paper
• Training and Fidelity Monitoring of Alcohol Treatment Interventions Integrated Into Routine Tuberculosis Care in Tomsk, Russia: the IMPACT Effectiveness Trial

  2013influential citation
• Buprenorphine Use in Pregnant Opioid Users: A Critical Review

  2013cites this paper
• Alcohol withdrawal delirium - diagnosis, course and treatment.

  2013cites this paper
• The Importance of Quality of Life in Patients with Alcohol Abuse and Dependence

  2013cites this paper
• Can sexual offenders be treated?

  2013cites this paper
• Abstinence dans l’alcoolodépendance : approche critique et actualisée des recommandations nationales de 2001

  2013cites this paper
• Wichtige Ergänzung zur Rezidivprophylaxe und Trinkmengenreduktion

  2013cites this paper
• Alkohol und Gewalt: Eine aktuelle Übersicht

  2012cites this paper
• Tragic Logic or How Evidence Does Not Change Convictions: The Perception of Geneva’s Addictology Caregivers Concerning the Utility of Disulfiram

  2012cites this paper
• Integrating addiction and mental health networks to improve access to treatment for people with alcohol and drug‐related problems: a qualitative study

  2012cites this paper
• Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence

  2012cites this paper
• Alcohol Craving, Glutamate and Acamprosate

  2012cites this paper
• Psychopharmakotherapie: klinisch-empirische Grundlagen

  2011cites this paper
• The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.

  2011cites this paper
• The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence

  2011influential citation
• Therapeutic Drug Monitoring for Drugs Used in the Treatment of Substance-Related Disorders: Literature Review Using a Therapeutic Drug Monitoring Appropriateness Rating Scale

  2011cites this paper
• Schizophrenia and Comorbid Substance Abuse – Pathophysiological and Therapeutic Approaches

  2011cites this paper
• Caractérisation de la prescription et des effets du Baclofène (Liorésal®) dans le traitement des dépendances de type alcool ou autres

  2011influential citation
• Pharmakotherapie der Alkoholabhängigkeit

  2011cites this paper
• Barriers to Use of Pharmacotherapy for Addiction Disorders and How to Overcome Them

  2011cites this paper
• Nüchterne Überlegungen zur Behandlung mit Disulfiram. Teil 1

  2010cites this paper
• Pre- and post-nicotine circadian activity episodes are differentially affected by pharmacological treatments for drug addiction

  2010cites this paper
• Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment.

  2010cites this paper
• The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of paraphilias

  2010cites this paper
• Comorbidity of personality disorders with alcohol abuse.

  2010cites this paper
• Nalmefene for treatment of alcohol dependence

  2010cites this paper
• Feasability and safety of transfer from racemic methadone to (R)-methadone in primary care: Clinical results from an open study

  2009cites this paper
• Successful Treatment of Chronic Resistant Alcoholism by Deep Brain Stimulation of Nucleus Accumbens: First Experience with Three Cases

  2009cites this paper
• Acute Maniform Reaction to a Single Dose of Escitalopram in a Social Phobic Patient – An Atypical Jitteriness Syndrome?

  2009cites this paper
• Pharmacotherapy of patients with schizophrenia and substance abuse

  2009influential citation
• [Treatment outcome after inpatient alcohol withdrawal: impact of motivational interventions: a comparative study].

  2009cites this paper
• Pharmacological treatment of mental disorders in primary health care

  2009cites this paper
• The implications of medication development in the treatment of substance use disorders in developing countries

  2009cites this paper
• Behandlungserfolg nach qualifiziertem Alkoholentzug

  2009cites this paper
• How to grade categories of evidence

  2008cites this paper
• Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.

  2008cites this paper
• Prevalence of delirium tremens.

  2008cites this paper
• Letter to the Editor Prevalence of Delirium Tremens

  2008cites this paper
• Medikamente zur Behandlung von Abhängigkeit und Entzugssymptomen

  2008cites this paper
• Pharmacological treatment of alcohol hallucinosis.

  2008cites this paper
• A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder

  2007cites this paper
• Pharmacological treatment options for panic disorder in children and adolescents

  2006cites this paper